BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 7862533)

  • 1. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
    Hamilton TB; Barilla KC; Romaniuk PJ
    Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
    Zhai G; Iskandar M; Barilla K; Romaniuk PJ
    Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.
    Hamilton TB; Borel F; Romaniuk PJ
    Biochemistry; 1998 Feb; 37(7):2051-8. PubMed ID: 9485332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
    Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
    Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
    Nakagama H; Heinrich G; Pelletier J; Housman DE
    Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
    Lee YI; Kim SJ
    DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
    Bardeesy N; Pelletier J
    Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
    Laity JH; Chung J; Dyson HJ; Wright PE
    Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
    Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
    Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A zinc finger directory for high-affinity DNA recognition.
    Jamieson AC; Wang H; Kim SH
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12834-9. PubMed ID: 8917505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
    Sakamoto Y; Yoshida M; Semba K; Hunter T
    Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1.
    Ward A; Pooler JA; Miyagawa K; Duarte A; Hastie ND; Caricasole A
    Gene; 1995 Dec; 167(1-2):239-43. PubMed ID: 8566784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers.
    Laity JH; Dyson HJ; Wright PE
    J Mol Biol; 2000 Jan; 295(4):719-27. PubMed ID: 10656784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wilms' tumor suppressor gene WT1 is negatively autoregulated.
    Rupprecht HD; Drummond IA; Madden SL; Rauscher FJ; Sukhatme VP
    J Biol Chem; 1994 Feb; 269(8):6198-206. PubMed ID: 8119964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.